|24th November 2020||Capital Managing Member Iv, Llc Avista||100||Open or private purchase||$5.00||$500.00|
|20th November 2020||Capital Managing Member Iv, Llc Avista||2,739||Open or private purchase||$4.99||$13,670.62|
|17th November 2020||Arthur S Leibowitz||6,943||Open or private purchase||$3.25||$22,564.75|
|17th November 2020||Glenn H Nussdorf||347,153||Open or private purchase||$3.25||$1,128,247.25|
|17th November 2020||Alan A. Ades||347,153||Open or private purchase||$3.25||$1,128,247.25|
|17th November 2020||Glenn H Nussdorf||486,000||Open or private purchase||$3.25||$1,579,500.00|
|17th November 2020||Alan A. Ades||486,000||Open or private purchase||$3.25||$1,579,500.00|
|22nd April 2020||Wayne D Mackie||18,564||Grant/award etc.||$0.00|
|22nd April 2020||Joshua Alexander Tamaroff||18,564||Grant/award etc.||$0.00|
|22nd April 2020||Arthur S Leibowitz||18,564||Grant/award etc.||$0.00|
Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 9/10.
Organogenesis Holdings, Inc. focuses on the development, manufacture and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company was founded in 1985 and is headquartered in Canton, MA.